Rani Therapeutics Holdings, Inc. Class A (RANI)
NASDAQ:RANI
| Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.03M | $ 0.00 | $ 0.00 | $ 2.72M |
| Gross Profit | $ 0.00 | $ 1.03M | $ -822.00K | $ 0.00 | $ 2.72M |
| Operating Income | $ -38.31M | $ -53.31M | $ -66.10M | $ -63.45M | $ -51.60M |
| EBITDA | $ -38.31M | $ -50.52M | $ -65.28M | $ -61.66M | $ -52.08M |
| Net Income | $ -29.67M | $ -30.02M | $ -33.97M | $ -30.59M | $ -8.33M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 49.71M | $ 27.64M | $ 48.54M | $ 98.48M | $ 117.45M |
| Total Assets | $ 58.62M | $ 36.63M | $ 57.92M | $ 108.03M | $ 124.21M |
| Total Debt | $ 4.32M | $ 29.71M | $ 30.10M | $ 30.21M | $ 0.00 |
| Net Debt | $ -14.30M | $ 25.95M | $ 24.23M | $ 3.21M | $ -117.45M |
| Total Liabilities | $ 17.11M | $ 33.14M | $ 32.47M | $ 34.02M | $ 2.64M |
| Stockholders' Equity | $ 33.01M | $ 1.99M | $ 12.87M | $ 36.85M | $ 47.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.80M | $ -35.76M | $ -52.47M | $ -48.13M | $ -32.75M |
| Operating Cash Flow | $ -18.71M | $ -35.50M | $ -51.24M | $ -46.52M | $ -32.24M |
| Investing Cash Flow | $ -7.03M | $ 19.81M | $ 29.86M | $ -72.44M | $ -506.00K |
| Financing Cash Flow | $ 40.30M | $ 13.59M | $ 233.00K | $ 29.00M | $ 77.15M |